Switch to:
Novo Nordisk A/S (NYSE:NVO)
Cash Flow for Capital Expenditures
$-935 Mil (TTM As of Sep. 2016)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Novo Nordisk A/S's cash flow for capital expenditures for the six months ended in Sep. 2016 was $-392 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2016 was $-935 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novo Nordisk A/S Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Sep. 2016 was $-935 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Novo Nordisk A/S Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Cash Flow_CPEX -588-474-370-600-690-590-637-669-714-935

Novo Nordisk A/S Semi-Annual Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
Cash Flow_CPEX -162-187-255-116-171-195-464-170-265-392
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK